Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation

Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation

Atrial fibrillation (AF) and heart failure frequently coexist. Prediction of left ventricular ejection fraction (LVEF) recovery after catheter ablation (CA) for AF remains difficult. The purpose of this study was to evaluate the value of biomarkers, alone and in combination with the Antwerp score, t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart rhythm 2024-09, Vol.21 (9), p.1581-1588
Hauptverfasser: Serban, Teodor, Hennings, Elisa, Strebel, Ivo, Knecht, Sven, du Fay de Lavallaz, Jeanne, Krisai, Philipp, Arnet, Rebecca, Völlmin, Gian, Osswald, Stefan, Sticherling, Christian, Kühne, Michael, Badertscher, Patrick
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Angiopoietin 2
Antwerp score
Atrial fibrillation
Atrial Fibrillation - diagnosis
Atrial Fibrillation - physiopathology
Atrial Fibrillation - surgery
Biomarker
Biomarkers - blood
Catheter ablation
Catheter Ablation - methods
Ejection fraction
Female
Follow-Up Studies
Growth differentiation factor 15
Growth Differentiation Factor 15 - blood
Heart failure
Humans
Male
Middle Aged
Pulmonary vein isolation
Recovery of Function
Stroke Volume - physiology
Ventricular Function, Left - physiology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Atrial fibrillation (AF) and heart failure frequently coexist. Prediction of left ventricular ejection fraction (LVEF) recovery after catheter ablation (CA) for AF remains difficult. The purpose of this study was to evaluate the value of biomarkers, alone and in combination with the Antwerp score, to predict LVEF recovery after CA for AF. Patients undergoing CA for AF with depressed LVEF (
ISSN:1547-5271
1556-3871
1556-3871
DOI:10.1016/j.hrthm.2024.04.044